Thus, this study indicated that at least in the settings of activated Kras oncogene in murine livers, the amount of Pten alleles and the timing of transgene modification can, to a large extent, dictate whether a liver cancer CoO will give rise to HCC or iCCA. The gene discussed is PTEN; the disease is liver cancer.